Delivery Order SPE2DB20D3101-SPE2DB25FRUY1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a ceiling value of $17,820.70. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $28,354.52 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $36,034.88 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units) valued at $20,738.24 under a firm fixed price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a $12,436.60 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (180 count). This competitive, firm fixed-price contract involves no set-aside designation and requires delivery by September 11, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $22,232.86 to supply Entresto 97 mg-103 mg tablets (180-count) with an ultimate completion date of August 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,506.82 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count package) on September 10, 2025, with completion scheduled for September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUY1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Entresto 24 mg–26 mg tablets (180 count) at a ceiling value of $2,242.14. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical through December 2026 that serves as the primary vehicle for pharmaceutical procurement across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This award for Entresto, a heart failure medication, reflects AmerisourceBergen's critical role in supplying pharmaceutical products to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/10/25 |